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Abstract
Background: Healthy individuals can host Staphylococcus aureus in the nasopharynx, body surface and vagina. Most
invasive infections by this bacterium are endogenous, caused by strains spread from the nasopharynx of carriers. S.
aureus is a pathogen involved in the etiology of hospital- and community-acquired infections. Transplant and dialysis
patients are at risk of colonization or infection by multi-resistant S. aureus. Infection is directly linked to individual
immunity, and the major histocompatibility complex (MHC) plays a crucial role in determining susceptibility to diseases.
Different MHC specificities have been shown to be more frequent in individuals suffering from certain diseases. This
study aimed to investigate the association between HLA class I (HLA-A and -B) and class II (HLA-DRB1) molecules and
nasal carriage of S. aureus in dialysis and kidney transplant patients at a hospital in Southern Brazil.
Results: The sample consisted of 70 dialysis and 46 kidney transplant patients, totaling 116 patients. All subjects
were typed for HLA molecules using LABType
® SSO (One Lambda). Nasal swab samples of S. aureus were isolated
from the nasal cavity (both nostrils) of patients undergoing dialysis or kidney transplantation.
In renal dialysis patients, HLA-A*02 was the most frequent allele in both carriers (25.5%) and non-carriers (21.2%) of
S. aureus. Allele A*68 was not observed in the carrier group, but the allele was observed six times in the non-
carrier group (p = 0.0097). Regarding HLA-B and HLA-DRB1, no allele was shown to be involved in protection
against or susceptibility to carriage of S. aureus. In kidney transplant patients, allele A*03 was more frequent in the
non-carrier (20.83%) than in the carrier (5.88%) group (p = 0.0486). HLA-B*15 was present in carriers (5.88%) and
non-carriers (25%) (p = 0.0179). Regarding class II alleles, DRB1*03 appeared to be related to susceptibility to
carriage of S. aureus (p = 0.0319).
Conclusions: Our findings suggest that HLA-DRB1*03 may be involved in susceptibility to nasal carriage of S.
aureus in transplant patients. In addition, HLA-A*68 (dialysis patients) and HLA-A*03 and HLA-B*15 (transplant
patients) appear to be associated with increased resistance to S. aureus nasal carriage.
Background
Staphylococcus aureus is considered an important etiolo-
gic agent due to its high frequency and pathogenicity,
causing diseases in both healthy and immunocompro-
mised individuals. This microorganism is able to spread
easily in the hospital environment and to develop resis-
tance to antimicrobial agents [1,2].
Approximately 20% of adults are carriers of S. aureus
in the nasopharynx, another 30% carry it intermittently,
and 50% are not carriers [3,4]. Persistent nasal carriers
of S. aureus are at higher risk of developing infection
[5,6]. Dialysis and kidney transplant patients are particu-
larly prone to infection due to constant exposure to risk
factors and immunosuppression [2,7].
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the major histocompatibility complex (MHC)–as e to f
genes found on the short arm of human chromosome
6–plays a crucial role in determining susceptibility to
diseases. Specifically, MHC contains a group of genes
that code for several proteins expressed on the surface
of a variety of cell types. In humans, these molecules are
known as human leukocyte antigens (HLA) [8].
Molecules of the HLA system are classified as class I
(HLA-A, -B and -C), class II (HLA-DR, -DQ and -DP),
and class III. These molecules are highly polymorphic
glycoproteins that differentiate themselves from one
another by their location in tissues and their function.
Class I molecules are present on the surface of all
nucleated cells and are responsible for presenting pep-
tides to cytotoxic T cells (CD8
+). Class II molecules are
distributed less widely, being found primarily on the
surface of cells linked directly to the immune response
(such as macrophages, monocytes, dendritic cells, Lan-
gerhans cells, B lymphocytes, and activated T lympho-
cytes), with the purpose of presenting peptides to
regulatory T cells (CD4
+). The class III region does not
encode histocompatibility molecules, but rather other
molecules such as tumor necrosis factors, C4 and C2
proteins, complement factor B, heat shock protein, and
21-hydroxylase enzyme [9-12].
Different HLA specificities have been shown to be
more frequent in individuals suffering from certain dis-
eases, and characterizing these molecules may have
important clinical implications [13-15].
The role of the HLA system in pathogenesis has been
studied in several diseases, such as skin diseases [16-18],
tuberculosis [19,20], psychiatric illnesses [21,22], as well
as hearing [23,24], sight [25,26] and kidney [27] pro-
blems. Nasal carriage of Staphylococcus spp. has been
investigated in dialysis and kidney transplant patients
[28,29]; however, only a few studies have investigated
the involvement of genetic factors in this carriage. A lit-
erature review returned only one study, published in
1983, investigating the association between HLA mole-
cules and nasal carriage of S. aureus in healthy labora-
tory workers and outpatients [30].
Thus, this study aimed to investigate the association
between HLA class I (HLA-A and -B) and class II
(HLA-DRB1) molecules and nasal carriage of S. aureus
in dialysis and kidney transplant patients at a hospital in
Southern Brazil.
Methods
The study population consisted of 70 renal patients
undergoing dialysis and 46 kidney transplant patients,
totaling 116 patients. All subjects were typed for HLA
class I (A, B) and class II (DRB1) molecules and evalu-
ated for nasal carriage. Biological material, nasal
discharge and blood were collected between June and
November 2009.
Staphylococcus aureus identification
Nasal swab samples of S. aureus were isolated from the
nasal cavity of patients undergoing dialysis or kidney
transplantation by inserting sterile swabs into both nos-
trils. The material was placed in Petri dishes (90 × 15
mm) containing mannitol salt agar (MSA) (Becton Dick-
inson & Co., BD Diagnostic Systems, USA), transferred
to a test tube containing trypticase soy broth (TSB) with
6.5% NaCl, and then placed in a stove for 24 hours. After
24-48 hours of incubation at 37°C, suspected S. aureus
colonies were subjected to Gram staining and immersion
microscopy. Those identified as Gram-positive cocci
arranged in grape-like clusters were transferred to a TSB
medium with 6.5% NaCl. The tube coagulase test was
performed after six hours of incubation. After the identi-
fication tests, samples were stored in a TSB medium with
glycerol (20%) and frozen at -20°C for later analysis.
HLA typing
Human DNA extraction: Peripheral blood was collected
by venipuncture in vacuum tubes containing EDTA
anticoagulant, and genomic DNA was extracted using
EZ-DNA reagent, according to the manufacturer’s
instructions (Biological Industries, Kibbutz Beit, Hae-
mek, Israel).
Genetic polymorphism of HLA molecules: One
Lambda LABType
® SSO kit was used in combination
with the Luminex™ technology for typing of HLA class
I (HLA-A and -B) and class II (HLA-DRB1) alleles.
Statistical analysis
For data analysis, dialysis and transplant patients were
subdivided into carriers and non-carriers of S. aureus.
The number of times a given allele was found (n) and
allele frequency (Af) were quantified in both patient
groups. P-value was calculated using Fisher’se x a c tt e s t
(P-value). Bonferroni correction (Pc-value) was used to
calculate p values below 0.05. The odds ratio (OR) and
confidence interval (95%CI) were calculated whenever
the p value was lower than 0.05.
Ethical aspects
The study was approved by the Research Ethics Commit-
tee of Universidade Estadual de Maringá (protocol no.
212/2009), and written informed consent was obtained
from all participants. The study was conducted in accor-
dance with the provisions of the Declaration of Helsinki.
Results
Of 70 dialysis patients, 30 (42.8%) were female and 40
( 5 7 . 1 % )m a l e .A g er a n g e df r o m2 2t o8 5y e a r s .T h i r t y -
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Page 2 of 6seven patients (52.8%) were nasal carriers of S. aureus
and 33 (47.1%) were non-carriers.
Of 46 patients evaluated in the transplant group, 16
(34.7%) were female and 30 (65.2%) male. Age ranged
from 18 to 64 years. Thirty-four patients (74%) were nasal
carriers of S. aureus and 12 (26%) were non-carriers.
Study association with dialysis patients and their status
as nasal carriers or non-carriers of Staphylococcus aureus
Analysis of the frequency of class I, A and B alleles, and
class II, DRB1 alleles, (Table 1) showed that HLA-A*02
was the most frequent allele in both carriers (25.5%)
and non-carriers (21.2%). HLA-A*68 was not observed
in the carrier group, but the allele was observed six
times in the non-carrier group (p = 0.0097). This result
suggests a tendency towards protection or resistance
against nasal carriage of S. aureus.R e g a r d i n gH L A - B
and -DRB1, no allele was shown to be involved in pro-
tection against or susceptibility to carriage of S. aureus.
Study association with kidney transplant patients and
their status as nasal carriers or non-carriers of
Staphylococcus aureus
As shown in Table 2, HLA-A*03 was more frequent in
the non-carrier group (20.83%) than in the carrier group
(5.88%) (p = 0.0486), which suggests a tendency towards
Table 1 Allele frequency (HLA-A, HLA-B, and HLA-DRB1) in the group of renal patients undergoing dialysis, nasal
carriers and non-carriers of Staphylococcus aureus
Carriers Non-carriers Carriers Non-carriers
Allele n Af%n Af% P-value Pc-value OR 95%CI Allele n Af%n Af% P-value Pc-value OR 95%CI
HLA-A HLA-B
01 9 12.1 6 9.0 ns - 05 0 - 1 1.5 ns -
02 19 25.6 14 21.2 ns - 07 4 5.4 6 9.0 ns -
03 6 8.1 7 10.6 ns - 08 4 5.4 5 7.5 ns -
11 6 8.1 4 6.0 ns - 13 1 1.3 0 - ns -
23 2 2.7 2 3.0 ns - 14 0 - 2 3.0 ns -
24 9 12.1 10 15.1 ns - 15 1 1.3 3 4.5 ns -
25 3 4.0 0 - ns - 16 0 - 1 1.5 ns -
26 2 2.7 5 7.5 ns - 18 7 9.4 6 9.0 ns -
29 3 4.0 1 1.5 ns - 22 1 1.3 0 - ns -
30 5 6.7 5 7.5 ns - 27 2 2.7 0 - ns -
31 3 4.0 1 1.5 ns - 35 6 8.1 4 6.0 ns -
32 2 2.7 2 3.0 ns - 38 3 4.0 3 4.5 ns -
33 2 2.7 2 3.0 ns - 39 3 4.0 4 6.0 ns -
34 2 2.7 1 1.5 ns - 40 1 1.3 2 3.0 ns -
68 0 - 6 9.0 0.0097 0.1552 - - 41 0 - 1 1.5 ns -
74 1 1.3 0 - ns - 42 2 2.7 1 1.5 ns -
HLA-DRB1 44 6 8.1 5 7.5 ns -
01 3 4.0 5 7.5 ns - 45 2 2.7 0 - ns -
03 1 1.3 2 3.0 ns - 49 2 2.7 2 3.0 ns -
04 10 13.5 13 19.7 ns - 50 1 1.3 3 4.5 ns -
07 8 10.8 6 9.0 ns - 51 7 9.4 8 12.1 ns -
08 5 6.7 2 3.0 ns - 52 2 2.7 2 3.0 ns -
09 1 1.3 0 - ns - 53 1 1.3 2 3.0 ns -
10 3 4.0 3 4.5 ns - 55 4 5.4 0 - ns -
11 17 22.9 11 16.6 ns - 57 3 4.0 0 - ns -
13 6 8.1 7 10.6 ns - 58 1 1.3 2 3.0 ns -
14 5 6.7 1 1.5 ns - 60 2 2.7 1 1.5 ns -
15 3 4.0 7 10.6 ns - 61 2 2.7 0 - ns -
16 5 6.7 6 9.0 ns - 62 4 5.4 0 - ns -
17 3 4.0 3 4.5 ns - 65 1 1.3 2 3.0 ns -
18 1 1.3 0 - ns - 81 1 1.3 0 - ns -
51 1 1.3 0 - ns -
52 2 2.7 0 - ns -
N number of times the allele was found; Af allele frequency; P-value = calculated by Fisher’s exact test; Pc-value = Bonferroni-corrected P-value; OR odds ratio;
95%CI 95% confidence interval; ns non-significant (p > 0.05)
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showed a trend towards protection against carriage (car-
riers: 5.88%; non-carriers: 25%) (p = 0.0179). Regarding
class II alleles, DRB1*03 appeared to be related to sus-
ceptibility to carriage of S. aureus (p = 0.0319).
Discussion
The molecules of the HLA system, which are directly
linked to the immune response, play a crucial role in the
susceptibility to or protection against infectious diseases
[31]. The determination of th e s em o l e c u l e si so f t e nu s e d
in association studies with various illnesses, allowing a
search for specific markers of susceptibility or resistance
[32,33]. In our study, we demonstrated that certain HLA
alleles could be involved in nasal carriage of S. aureus in
dialysis and kidney transplant patients.
During the literature review, we found only one
study on HLA and nasal carriage of S. aureus [30],
which employed the serological method of HLA typing.
That study analyzed healthy laboratory workers and
patients attending an outpatient clinic in Dublin and
Galway, Ireland. A positive association was found
between HLA-DR3 antigen and carriage of S. aureus,
making individuals more susceptible to carrying the
bacterium. Class I (HLA-Bw35) and class II (HLA-DR2
and HLA-DR1) antigens were also shown to be
Table 2 Allele frequency (HLA-A, HLA-B, and HLA-DRB1) in the group kidney transplant patients, nasal carriers and
non-carriers of Staphylococcus aureus
Carriers Non-
carriers
Carriers Non-
carriers
Allele n Af%nAf% P-value Pc-value OR 95%CI Allele n Af%nAf% P-value Pc-value OR 95%CI
HLA-A HLA-B
01 9 13.24 2 8.33 ns - 07 5 7.35 1 4.17 ns
02 21 30.88 6 25.0 ns - 08 6 8.82 0 - ns
03 4 5.88 5 20.83 0.0486 0.7776 0.2375 0.0579-0.9738 12 0 - 1 4.17 ns
11 2 2.94 0 - ns - 13 2 2.94 1 0.417 ns
23 1 1.47 1 4.17 ns - 14 3 4.41 0 - ns
24 9 13.24 2 8.33 ns - 15 4 5.88 6 25.0 0.0179 0.4833 0.1875 0.0477-0.7371
26 2 2.94 1 4.17 ns - 18 2 2.94 1 4.17 ns
28 0 - 1 4.17 ns - 27 0 - 1 4.17 ns
29 4 5.88 0 - ns - 35 8 11.76 2 8.33 ns
30 6 8.82 1 4.17 ns - 37 2 2.94 1 4.17 ns
31 2 2.94 1 4.17 ns - 38 1 1.47 0 - ns
32 1 1.47 1 4.17 ns - 39 2 2.94 0 - ns
33 3 4.41 0 - ns - 40 1 1.47 3 12.50 ns
36 1 1.47 0 - ns - 41 1 1.47 1 4.17 ns
66 1 1.47 0 - ns - 42 1 1.47 0 - ns
68 2 2.94 3 12.50 ns - 44 5 7.35 3 12.50 ns
HLA-DRB1 45 2 2.94 0 - ns
01 3 4.41 0 - ns - 47 0 - 1 4.17 ns
03 12 17.65 0 - 0.0319 0.4785 49 4 5.88 0 - ns
04 9 13.24 3 12.50 ns - 51 6 8.82 1 4.17 ns
07 3 4.41 4 16.67 ns - 52 3 4.41 0 - ns
08 2 2.94 2 8.33 ns - 53 1 1.47 0 - ns
09 3 4.41 1 4.17 ns - 55 1 1.47 0 - ns
10 0 - 1 4.17 ns - 57 4 5.88 0 - ns
11 13 19.12 6 25.0 ns - 58 2 2.94 1 4.17 ns
12 0 - 2 8.33 ns - 62 1 1.47 0 - ns
13 6 8.82 1 4.17 ns - 70 1 1.47 0 - ns
14 5 7.35 0 - ns -
15 7 10.29 2 8.33 ns -
16 2 2.94 2 8.33 ns -
17 2 2.94 0 - ns -
18 1 1.47 0 - ns -
N number of times the allele was found; Af allele frequency; P-value = calculated by Fisher’s exact test; Pc-value = Bonferroni-corrected P-value; OR odds ratio;
95%CI 95% confidence interval; ns non-significant (p > 0.05)
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bacterium.
The present study contributed to confirm the involve-
ment of HLA-DRB1*03 (serological equivalent DR3) as
a possible genetic marker for susceptibility to nasal car-
riage of S. aureus. It also contributed to demonstrate
the involvement of HLA class I specificities (-A*03,
-A*68, and -B*15) as protective factors against nasal car-
riage of S. aureus in renal patients.
The importance of identifying patients carrying S. aur-
eus, in particular those with a multi-resistant profile, lies
in the fact that this pathogen is linked to endogenous
infections [34]. In that sense, it is worth noting that
infectious diseases exert selective genetic pressure, and
the genes involved in the immune response are the
most numerous and polymorphic of the human genome,
thereby indicating the evolutionary advantages of the
immune response to a wide variety of pathogens. This is
evidenced by the participation of HLA in the presenta-
tion of foreign peptides to immune system cells [35].
Conclusions
Our findings suggest that HLA-DRB1*03 may be
involved in susceptibility to nasal carriage of S. aureus
in transplant patients. In addition, HLA-A*68 (dialysis
patients) and HLA-A*03 and HLA-B*15 (transplant
patients) appear to be associated with increased resis-
tance to S. aureus nasal carriage.
Further studies are warranted to clarify the role of
HLA as a genetic marker in resistance against or sus-
ceptibility to carriage of S. aureus. Establishing the role
of host genetic factors should contribute to a better
understanding of infectious conditions as well as to
develop new therapies according to the progress in the
field of pharmacogenetics.
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